MALCOLM BRENNER to Clinical Trials as Topic
This is a "connection" page, showing publications MALCOLM BRENNER has written about Clinical Trials as Topic.
Connection Strength
0.282
-
Immunotherapy against cancer-related viruses. Cell Res. 2017 Jan; 27(1):59-73.
Score: 0.067
-
The eyes have it. Mol Ther. 2010 Mar; 18(3):451-2.
Score: 0.042
-
American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther. 2003 Aug; 8(2):180-7.
Score: 0.027
-
Evidence-based regulation--a personal view. Mol Ther. 2002 Aug; 6(2):137.
Score: 0.025
-
"The end of the beginning": molecular and cellular biology of gene therapy keystone. 14-20 January 1999. Biochim Biophys Acta. 1999 Jul 29; 1424(1):R5-9.
Score: 0.020
-
BMT beats autoimmune disease. Nat Med. 1998 Feb; 4(2):153-5.
Score: 0.018
-
Gene transfer and the treatment of childhood cancer. Cancer Invest. 1998; 16(4):269-78.
Score: 0.018
-
Gene transfer in haematological malignancy. Ann Med. 1996 Dec; 28(6):491-7.
Score: 0.017
-
Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010 Sep; 12(5):576-8.
Score: 0.011
-
In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. Blood. 1989 Sep; 74(4):1374-80.
Score: 0.010
-
Progress and prospects: gene therapy clinical trials (part 2). Gene Ther. 2007 Nov; 14(22):1555-63.
Score: 0.009
-
Immune therapy for EBV infections after hemopoietic stem-cell transplant. Cytotherapy. 2002; 4(5):433-4.
Score: 0.006
-
Human gene marker/therapy clinical protocols. Hum Gene Ther. 1996 Dec 01; 7(18):2287-313.
Score: 0.004
-
Gene therapy: socioeconomic and ethical issues. A roundtable discussion. Hum Gene Ther. 1996 Jun 10; 7(9):1139-44.
Score: 0.004
-
A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients. J Antimicrob Chemother. 1989 May; 23(5):759-71.
Score: 0.002
-
Do double-beta-lactam combinations prolong neutropenia in patients undergoing chemotherapy or bone marrow transplantation for hematological disease? Antimicrob Agents Chemother. 1989 Apr; 33(4):503-7.
Score: 0.002